Post-Acute COVID-19 Syndrome and the Cardiovascular System: What is Known?

Overview

Journal Am Heart J Plus

Specialty Cardiology & Vascular Diseases

Date 2021 Jun 30

PMID 34192289

Citations 52

Authors

Neal M Dixit

Austin Churchill

Ali Nsair

Jeffrey J Hsu

Affiliations

Soon will be listed here.

Abstract

Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms >3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rarely causes direct myocardial injury, several syndromes such as myocarditis, pericarditis, and Postural Orthostatic Tachycardia Syndrome have been implicated in PACS. Additionally, patients hospitalized with acute COVID-19 who display biomarker evidence of myocardial injury may have underlying coronary artery disease revealed by the physiological stress of SARS-CoV-2 infection and may benefit from medical optimization. We review what is known about PACS and the cardiovascular system and propose a framework for evaluation and management of related symptoms.

Citing Articles

Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics.

Talkington G, Kolluru P, Gressett T, Ismael S, Meenakshi U, Acquarone M Front Neurol. 2025; 15:1465787.

PMID: 40046430 PMC: 11881597. DOI: 10.3389/fneur.2024.1465787.

Potential Correlation Between Hematological Parameters and Palpitation in Outpatients With COVID-19: A Retrospective Study.

Zhang L, Chen T, Wei L, Ren J, Gong J, Yuan H J Clin Lab Anal. 2025; 39(2):e25137.

PMID: 39810499 PMC: 11776496. DOI: 10.1002/jcla.25137.

Perioperative cardiovascular risk and preventions of patients with post-COVID-19 condition.

Lai S, Min S Heliyon. 2024; 10(20):e39345.

PMID: 39640715 PMC: 11620228. DOI: 10.1016/j.heliyon.2024.e39345.

Long COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems.

Merhavy Z, Junor T, Gonzalez A, De Filippis S, Oveisitork S, Rivera E Korean J Fam Med. 2024; 45(6):305-316.

PMID: 39600184 PMC: 11605154. DOI: 10.4082/kjfm.24.0085.

Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation through the Retrospective Analysis of 152 Patients.

Colombo J, Weintraub M, Munoz R, Verma A, Ahmad G, Kaczmarski K NeuroSci. 2024; 3(2):300-310.

PMID: 39483361 PMC: 11523758. DOI: 10.3390/neurosci3020021.

References

Castro-Marrero J, Saez-Francas N, Santillo D, Alegre J . Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017; 174(5):345-369. PMC: 5301046. DOI: 10.1111/bph.13702. View

Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton G . Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging. 2021; 14(11):2155-2166. PMC: 8105493. DOI: 10.1016/j.jcmg.2021.04.011. View

Shouman K, Vanichkachorn G, Cheshire W, Suarez M, Shelly S, Lamotte G . Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021; 31(3):385-394. PMC: 8050227. DOI: 10.1007/s10286-021-00803-8. View

Kamal M, Abo Omirah M, Hussein A, Saeed H . Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020; 75(3):e13746. PMC: 7536922. DOI: 10.1111/ijcp.13746. View

Darley D, Dore G, Cysique L, Wilhelm K, Andresen D, Tonga K . Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med J Aust. 2021; 214(6):279-280. PMC: 8014234. DOI: 10.5694/mja2.50963. View

Seshadri D, Davies E, Harlow E, Hsu J, Knighton S, Walker T . Wearable Sensors for COVID-19: A Call to Action to Harness Our Digital Infrastructure for Remote Patient Monitoring and Virtual Assessments. Front Digit Health. 2021; 2:8. PMC: 8521919. DOI: 10.3389/fdgth.2020.00008. View

Goodman B, Khoury J, Blair J, Grill M . COVID-19 Dysautonomia. Front Neurol. 2021; 12:624968. PMC: 8076737. DOI: 10.3389/fneur.2021.624968. View

Shang Y, Liu T, Yu J, Xu X, Zahid K, Wei Y . Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors. J Intern Med. 2021; 290(2):444-450. PMC: 8242565. DOI: 10.1111/joim.13284. View

Loo J, Spittle D, Newnham M . COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021; 76(4):412-420. DOI: 10.1136/thoraxjnl-2020-216243. View

10.

Rajpal S, Tong M, Borchers J, Zareba K, Obarski T, Simonetti O . Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2020; 6(1):116-118. PMC: 7489396. DOI: 10.1001/jamacardio.2020.4916. View

11.

Biehl M, Sese D . Post-intensive care syndrome and COVID-19 - Implications post pandemic. Cleve Clin J Med. 2020; . DOI: 10.3949/ccjm.87a.ccc055. View

12.

Lippi G, Lavie C, Sanchis-Gomar F . Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3):390-391. PMC: 7127395. DOI: 10.1016/j.pcad.2020.03.001. View

13.

de Graaf M, Antoni M, Ter Kuile M, Arbous M, Duinisveld A, Feltkamp M . Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach. EClinicalMedicine. 2021; 32:100731. PMC: 7843037. DOI: 10.1016/j.eclinm.2021.100731. View

14.

Aquaro G, Habtemicael Y, Camastra G, Monti L, Dellegrottaglie S, Moro C . Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. J Am Coll Cardiol. 2019; 74(20):2439-2448. DOI: 10.1016/j.jacc.2019.08.1061. View

15.

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

16.

Umapathi T, Poh M, Fan B, Li K, George J, Tan J . Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clin Auton Res. 2020; 30(6):571-573. PMC: 7511524. DOI: 10.1007/s10286-020-00733-x. View

17.

Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J . Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-1273. PMC: 7385689. DOI: 10.1001/jamacardio.2020.3557. View

18.

Starekova J, Bluemke D, Bradham W, Eckhardt L, Grist T, Kusmirek J . Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021; 6(8):945-950. PMC: 7809616. DOI: 10.1001/jamacardio.2020.7444. View

19.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View

20.

DeFilippis A, Chapman A, Mills N, de Lemos J, Arbab-Zadeh A, Newby L . Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. Circulation. 2019; 140(20):1661-1678. PMC: 6855329. DOI: 10.1161/CIRCULATIONAHA.119.040631. View